An animal formulation has been on the market for kidney compromised cats and dogs since 2006. No adverse effects in these animals have been observed. Recently completed results from human clinical trials have reaffirmed this safety.

We use cookies

We use cookies to improve your experience on this website. You may choose which types of cookies to allow and change your preferences at any time. Disabling cookies may impact your experience on this website. You can learn more by viewing our Cookie Policy.